Docoh
Loading...

249 results

Filter options loading...
Top filers
Top filing types
Recent filing years
10-Q
2021 Q2
PRPO Precipio Inc
12 Aug 21
Quarterly report
4:07pm
and aim to solve the growing problem of cancer misdiagnosis. In support of our platform, we also operate a research and development facility … of cancer diagnostics and aim to solve the growing problem of cancer misdiagnosis. In support of this platform, we also operate a research
10-Q
2021 Q1
PRPO Precipio Inc
14 May 21
Quarterly report
4:01pm
of cancer misdiagnosis. In support of our platform, we also operate a research and development facility in Omaha, Nebraska which focuses … of this platform, we also operate a research and development facility in Omaha, Nebraska which focuses on the development of various technologies, among them our
424B5
PRPO Precipio Inc
2 Apr 21
Prospectus supplement for primary offering
2:00pm
a research and development facility in Omaha, Nebraska which focuses on the development of various technologies, among them our internally developed … , including to support research and development, including clinical trials. However, we have not determined the specific allocation of the net proceeds
10-K
2020 FY
PRPO Precipio Inc
29 Mar 21
Annual report
4:29pm
care quality outcomes; promotes a more integrated health care delivery system and the creation of new health care delivery. Research and Development … Expenses For the years ended December 31, 2020 and 2019, we recorded $1.2 million, respectively, of research and development expenses. More information
10-Q
2020 Q3
PRPO Precipio Inc
13 Nov 20
Quarterly report
4:01pm
the growing problem of cancer misdiagnosis. We also operate a research and development facility in Omaha, Nebraska which focuses on development of various … from Dana-Farber Cancer Institute, Inc., or Dana-Farber, at Harvard University. The research and development center focuses on the development
10-Q
2020 Q2
PRPO Precipio Inc
13 Aug 20
Quarterly report
3:07pm
the growing problem of cancer misdiagnosis. We also operate a research and development facility in Omaha, Nebraska which focuses on development of various … from Dana-Farber Cancer Institute, Inc., or Dana-Farber, at Harvard University. The research and development center focuses on the development
424B3
PRPO Precipio Inc
7 Jul 20
Prospectus supplement
5:27pm
of cancer misdiagnosis. We also operate a research and development facility in Omaha, Nebraska which focuses on development of various technologies, among … Cancer Institute, Inc., or Dana-Farber, at Harvard University. The research and development center focuses on the development of these technologies, which
S-1
PRPO Precipio Inc
26 Jun 20
IPO registration
5:18pm
University. The research and development center focuses on the development of these technologies, which we believe will enable us to commercialize … , sales, marketing, commercialization and capital resources. These competitors may have substantial advantages over us in terms of research and development expertise, experience
10-Q
2020 Q1
PRPO Precipio Inc
14 May 20
Quarterly report
4:05pm
. The research and development center focuses on the development of these technologies, which we believe will enable us to commercialize … diagnostics and aim to solve the growing problem of cancer misdiagnosis. We also operate a research and development facility in Omaha, Nebraska which
424B3
PRPO Precipio Inc
13 Apr 20
Prospectus supplement
4:55pm
diagnostics and aim to solve the growing problem of cancer misdiagnosis. We also operate a research and development facility in Omaha, Nebraska which focuses … we exclusively license from Dana-Farber Cancer Institute, Inc., or Dana-Farber, at Harvard University. The research and development center focuses
S-3/A
PRPO Precipio Inc
9 Apr 20
Shelf registration (amended)
1:53pm
and aim to solve the growing problem of cancer misdiagnosis. We also operate a research and development facility in Omaha, Nebraska which focuses … exclusively licensed from Dana-Farber Cancer Institute, Inc., or Dana-Farber, at Harvard University. The research and development center focuses
S-1/A
PRPO Precipio Inc
8 Apr 20
IPO registration (amended)
3:41pm
and aim to solve the growing problem of cancer misdiagnosis. We also operate a research and development facility in Omaha, Nebraska which focuses … exclusively license from Dana-Farber Cancer Institute, Inc., or Dana-Farber, at Harvard University. The research and development center focuses
S-3
PRPO Precipio Inc
27 Mar 20
Shelf registration
4:51pm
the growing problem of cancer misdiagnosis. We also operate a research and development facility in Omaha, Nebraska which focuses on development … licensed from Dana-Farber Cancer Institute, Inc., or Dana-Farber, at Harvard University. The research and development center focuses on the development
S-1
PRPO Precipio Inc
27 Mar 20
IPO registration
4:31pm
problem of cancer misdiagnosis. We also operate a research and development facility in Omaha, Nebraska which focuses on development of various … Dana-Farber Cancer Institute, Inc., or Dana-Farber, at Harvard University. The research and development center focuses on the development
10-K
2019 FY
PRPO Precipio Inc
27 Mar 20
Annual report
3:47pm
diagnostics and aim to solve the growing problem of cancer misdiagnosis. We also operate a research and development facility in Omaha, Nebraska which … below, which we exclusively licensed from Dana-Farber Cancer Institute, Inc., or Dana-Farber, at Harvard University. The research and development center
424B3
PRPO Precipio Inc
30 Jan 20
Prospectus supplement
5:09pm
diagnostics and aim to solve the growing problem of cancer misdiagnosis. We also operate a research and development facility in Omaha, Nebraska which will focus … discussed below. The research and development center focuses on the development of these technologies, which we believe will enable us to commercialize
S-1/A
PRPO Precipio Inc
27 Jan 20
IPO registration (amended)
4:47pm
the growing problem of cancer misdiagnosis. We also operate a research and development facility in Omaha, Nebraska which will focus on further development … with significant research and development resources to small, specialized firms whose narrower product lines may allow them to be more effective
S-1
PRPO Precipio Inc
14 Jan 20
IPO registration
4:26pm
operate a research and development facility in Omaha, Nebraska which will focus on further development of various technologies, among them ICE-COLD-PCR … , at Harvard University, in addition to IV-Cell, and HemeScreen, further discussed below. The research and development center focuses on the development
10-Q
2019 Q3
PRPO Precipio Inc
13 Nov 19
Quarterly report
4:33pm
standard of cancer diagnostics and solve the growing problem of cancer misdiagnosis. We also operate a research and development facility in Omaha … Cancer Institute, Inc. (“Dana-Farber”) at Harvard University (“Harvard”). The research and development center focuses on the development of this technology
424B3
PRPO Precipio Inc
21 Aug 19
Prospectus supplement
5:28pm
to solve the growing problem of cancer misdiagnosis. We also operate a research and development facility in Omaha, Nebraska which will focus on further … . The research and development center focuses on the development of these technologies, which we believe will enable us to commercialize these and other